Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 3.21% is 38% above its 2-year average of 2.33%, near the high end of its 2-year range (1.68%–3.35%).
As of the fiscal period ended Tuesday, June 30, 2026. 24.09% above its 12-month average of 2.59%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 3.21%.
DEBT TO ASSETS RATIO
3.21%
DEBT TO ASSETS RATIO AVG TTM
2.59%
DEBT TO ASSETS RATIO AVG 3Y
N/A
DEBT TO ASSETS RATIO AVG 5Y
N/A
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+24.09%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+3467.71%
vs the sector median at left
Market Cap
$5.87B
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.87B
Debt to Assets Ratio
0.05%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.96B
Debt to Assets Ratio
0.52%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6.23B
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.48B
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| GRAIL Inc. (GRAL) | $5.86B | 3.21% | 2.59% | N/A | N/A |
| Kiniksa Pharmaceuticals International, plc (KNSA)vs › | $5.87B | 0.01% | N/A | N/A | N/A |
| Iovance Biotherapeutics, Inc. (IOVA)vs › | $5.87B | 0.05% | N/A | N/A | N/A |
| Kodiak Sciences Inc. (KOD)vs › | $5.95B | 0.37% | N/A | N/A | N/A |
| Ligand Pharmaceuticals Incorporated (LGND)vs › | $5.96B | 0.52% | N/A | N/A | N/A |
| CG Oncology Inc. (CGON)vs › | $5.64B | 0.01% | N/A | N/A | N/A |
| RadNet, Inc. (RDNT)vs › | $5.52B | 0.52% | N/A | N/A | N/A |
| Rhythm Pharmaceuticals, Inc. (RYTM)vs › | $6.23B | 0.01% | N/A | N/A | N/A |
| MiniMed Group, Inc. Common Stock (MMED)vs › | $5.48B | 0.01% | N/A | N/A | N/A |
| PTC Therapeutics, Inc. (PTCT)vs › | $5.34B | 0.21% | N/A | N/A | N/A |
Debt/Assets
3.2%
Debt/Equity
0.04
Current Ratio
10.95
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 3.21% |
| 2026-03-31 | 1.82% |
| 2025-12-31 | 3.35% |
| 2025-09-30 | 2.25% |
| 2025-06-30 | 2.30% |
| 2025-03-31 | 2.26% |
| 2024-12-31 | 2.28% |
| 2024-09-30 | 2.32% |
| 2024-06-30 | 2.33% |
| 2024-03-31 | 1.68% |
| 2023-12-31 | 1.85% |
